cancer drugs

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

cancer drugs
Nov 13, 2024, 16:25 | Insight
A clear picture of the ground reality
Bishal Gyawali, Associate Professor at Queen’s University, shared an article by S.S. Datta on LinkedIn,…
Nov 2, 2024, 21:32 | Insight
Shushan Hovsepyan: Are we overestimating the true benefits of cancer drugs?
Shushan Hovsepyan, Editor-in-Chief of the OncoDaily Medical Journal, shared a post on LinkedIn about a recent…
Oct 18, 2024, 15:17 | Drugs
Duffy - Null phenotype's impact on Cancer Drug Trials - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on Linkedin: '' Many clinical trials of new cancer drugs may…
Oct 15, 2024, 13:03 | Blog
Aparna Parikh: Thrilled to launch this initiative aimed to reverse early recurrences of cancer
Aparna Parikh posted the following on LinkedIn: “We are thrilled to launch this initiative bringing…
Oct 1, 2024, 08:28 | Blog
Daniel Michaeli: Key takeaways from our new article on breast cancer drugs
Daniel Michaeli shared a post on LinkedIn, about a recently published paper: Breast cancer drugs:…
Aug 4, 2024, 17:00 | Insight
Jacob Adashek: Patients with KRAS G12C Vascular Malformations with profound responses to Sotorasib
Jacob Adashek posted on X: “Razelle Kurzrock with hattrick 'Benign drivers' - cancer drugs repurposed…
Jul 29, 2024, 06:17 | Positive
Neal Augenstein: Been cancer-free for 14 months since 11/22
Neal Augenstein, Reporter at WTOP News, shared on X: “Glad to report a clear CT…
Jul 14, 2024, 22:08 | Blog
Ivan R. Gonzalez: Project Orbis: A global initiative to accelerate the review of cancer drugs in the US, Canada, and the UK
Ivan R. Gonzalez, Medical Oncologist at Comprehensive Oncology Center, Hospital Angeles Puebla, shared a post…
Jul 12, 2024, 11:48 | Blog
Danielle Carnival - Two topline goals for the Biden Cancer Moonshot
Danielle Carnival, Deputy Assistant to President Biden for the Cancer Moonshot, shared a post by National…
Jul 11, 2024, 00:42 | Drugs
David Fajgenbaum: Repurposing existing drugs for new indications is both faster and less expensive
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared on X:…
Jul 9, 2024, 15:37 | Insight
10 Most Promising Cancer Drugs in 2024: What Patients Need to Know
Navigating the world of cancer treatment can be overwhelming, especially with so many new drugs…
Jul 4, 2024, 08:19 | Blog
New features and enhancements with NCCN
National Comprehensive Cancer Network shared on LinkedIn: "New features and enhancements! NCCN continues to enhance…
Jul 1, 2024, 15:09 | Blog
Yüksel Ürün: Did you know the FDA approved cancer drugs target fewer than 200 proteins?
Yüksel Ürün shared a post on X: “Did you know the FDA approved cancer drugs…
Jun 24, 2024, 02:11 | Blog
Bishal Gyawali: Very productive meeting of the MCBS working group
Bishal Gyawali shared on X:               . "We had a…
Jun 18, 2024, 02:16 | Blog
Chibuike Okafor: Why those suffixes in Cancer drugs?
Chibuike Okafor, Online Tutor at Pristine eTutor, shared on LinkedIn: "Unlike conventional anticancer molecular entities that…
May 16, 2024, 16:51 | Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 13, 2024, 08:24 | Blog
Monica Bertagnolli: AI Tool Has Promise for Matching Cancer Drugs to Patients
Monica Bertagnolli shared a post on LinkedIn: ''AI Tool Using Single-Cell Data Has Promise for Optimally…
May 7, 2024, 04:49 | Blog
Emma Walmsley: Another quarter of excellent performance for GSK
Emma Walmsley, CEO of GSK Pharmaceuticals, shared a post on LinkedIn: "Today I'm delighted to…
May 1, 2024, 21:39 | Blog
It’s the one-two punch cancer treatment that ‘floats like a butterfly, and STINGs like a bee’! - WEHI (Walter and Eliza Hall Institute of Medical Research)
WEHI (Walter and Eliza Hall Institute of Medical Research) made the foll0wing post on LinkedIn:…
Apr 28, 2024, 16:36 | Blog
FDA Oncology: OCE's Project Facilitate processed 401 calls and 889 applications for oncology investigational drugs
FDA Oncology shared a post on X: "In 2023, OCE's Project Facilitate handled 401 phone…
Apr 28, 2024, 11:48 | Drugs
Tovorafenib has now been approved for young patients with relapsed or progressive pediatric low-grade glioma - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute recently shared on LinkedIn: "For more than a decade, a collaborative team…
Apr 25, 2024, 21:33 | Blog
C. Ola Landgren: It was an honor to present the EVIDENCE meta-analysis at ODAC
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Apr 25, 2024, 12:40 | Drugs
Piotr Wysocki: Similar activity of topotecan and liposomal irinotecan in second-line treatment of SCLC
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 19, 2024, 20:20 | Drugs
This new review article is all about Tagraxofusp for BPDCN - ACS Journal Cancer
ACS Journal Cancer recently shared on X: "This new review article from Wei Ying Jen,…
Apr 19, 2024, 17:58 | Drugs
Fumiko Ladd Chino: We want lawmakers to end drug shortages
Fumiko Ladd Chino shared a post on X: "I am here in DC ASCO Advocacy…
Apr 16, 2024, 11:25 | Drugs
Piotr Wysocki: Adjuvant olaparib improves outcomes of breast cancer patients with germinal BRCA1/2 mutations at the cost of slightly decreased quality of life
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 12, 2024, 12:10 | Insight
Piotr Wysocki: Cetuximab monotherapy maintenance after FOLFIRI may not be the optimal choice but can be considered in selected mCRC patients
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 11, 2024, 12:58 | Blog,Drugs
Most cancer drugs granted accelerated approval did not demonstrate benefit in overall survival - JAMA Oncology
JAMA Oncology shared on X/Twitter: "Most cancer drugs granted accelerated approval did not demonstrate benefit in…
Apr 8, 2024, 20:10 | Blog
Sujuan Ba: I had a wonderful opportunity last month to join a global effort to raise awareness and funds for pediatric cancer at the first Oncothon event hosted by OncoDaily
Feb 25, 2024, 14:57 | Blog
Robert Francomano: Significant change in regulatory priorities by the FDA
Robert Francomano, Chief Commercial Officer at SELLAS, shared on LinkedIn: "The recent emphasis by the…
Feb 8, 2024, 17:51 | Blog
Carla Johnson: Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable
Carla Johnson, Journalist and Medical Writer at the Associated Press, shared on X/Twitter: "Cancer patients…
Feb 2, 2024, 12:25 | Opinion
Bishal Gyawali: Want to get your mind blown about how insane cancer drug prices have become?
Bishal Gyawali, Medical Oncologist and Assistant Professor at Queen’s University, shared on X: "Want to…
Jan 28, 2024, 11:45 | Blog
Rebecca Shatsky: Why on earth would insurance get to decide how I practice medicine!
Rebecca Shatsky shared on X/Twitter: "Just found out an insurance company is trying to deny my…
Nov 26, 2023, 11:32 | Blog
Bettina Ryll: Welcome to Europe's Cancer Reality
Bettina Ryll, Founder of MPN Europe, shared a post by Violeta Astratinei, a Member of…
Sep 5, 2023, 17:07 | Insight
A new ICR study has provided insights into an important biological mechanism that supports survival of aggressive, hard-to-treat cancers. - The Institute of Cancer Research
Jun 25, 2023, 15:54 | Drugs
Our cancer medication system fails us, globally - Gevorg Tamamyan
Our cancer medication system fails us, globally! Quality cancer drugs are hard to access. Especially…
All: 36 Posts: 1 - 100
Special Coverage